DCM
CERE

Deuterium Capital Management’s Cerevel Therapeutics Holdings, Inc. Common Stock CERE Stock Holding History

Deuterium Capital Management’s Portfolio CERE Stock Details CERE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change % 		Capital Flow Portfolio Weight Portfolio Position
2024
Q3 		– Sell
-12,572
Closed -$514K – 58
2024
Q2 		$514K Hold
12,572
– – 0.87% 18
2024
Q1 		$531K Buy
+12,572
New +$531K 0.95% 19